Zhang Xiu-juan, Wang Zhi, Li Hai-hui, Yu Ling, Gao Shan
Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medicine University, Beijing 100043, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Dec;31(12):1393-6.
To study the association between the levels of serum resistin, visfatin and insulin resistance as well as β-cell dysfunction in the first-degree relatives (FDR) of type 2 diabetes mellitus (T2DM), and to investigate the role of these adipocytokines in pathogenesis of T2DM.
Serum levels of resistin, visfatin as well as fasting true insulin (FTI), proinsulin (FPI) levels were measured in 71 patients with newly diagnosed T2DM. 55 subjects with IGT/IFG and 174 NGT from first-degree relatives of T2DM, and 114 subjects of NGT without T2DM family history served as control group (NC). Insulin resistance was assessed by the homeostasis model assessment (HOMA-IR) and β-cell function was evaluated by HOMA-β and fasting PI-to-TI ratio (FPI/TI). Lipid profile, liver function and kidney function were also tested. Anthropometrical parameters such as body mass index (BMI), waist circumference and blood pressure were also recorded and life style and food intake spectrum investigated.
(1) There were no significant differences of serum resistin levels among the four groups (P>0.05). The serum resistin level was not correlated with HomA-IR, HomA-β and obesity markers (P>0.05).(2) The serum visfatin levels of DM group, IGT/IFG and NGT group were lower than the NC group (P<0.05). There were no significant difference among DM group, IGT/IFG group and NGT. The serum visfatin level was not correlated with HOMA-IR and obesity markers (P>0.05), but negatively correlated with fasting blood glucose, 2 h postprandial blood glucose and blood pressure (P<0.05).
The adipokine profile in FDRs of T2DM had distinctively altered before the development of impaired glucose tolerance. Serum levels of visfatin, showed a favorable effect on glucose metabolism also had a significant decrease on serum levels in the early stage of T2DM.
研究2型糖尿病(T2DM)一级亲属(FDR)血清抵抗素、内脂素水平与胰岛素抵抗及β细胞功能障碍之间的关系,并探讨这些脂肪细胞因子在T2DM发病机制中的作用。
测定71例新诊断T2DM患者血清抵抗素、内脂素水平以及空腹真胰岛素(FTI)、胰岛素原(FPI)水平。选取55例T2DM一级亲属中的糖耐量受损/空腹血糖受损(IGT/IFG)者和174例糖耐量正常(NGT)者,以及114例无T2DM家族史的NGT者作为对照组(NC)。采用稳态模型评估法(HOMA-IR)评估胰岛素抵抗,用HOMA-β和空腹胰岛素原与真胰岛素比值(FPI/TI)评估β细胞功能。同时检测血脂、肝功能和肾功能。记录人体测量参数如体重指数(BMI)、腰围和血压,并调查生活方式和食物摄入谱。
(1)四组血清抵抗素水平差异无统计学意义(P>0.05)。血清抵抗素水平与HOMA-IR、HOMA-β及肥胖指标均无相关性(P>0.05)。(2)糖尿病组、IGT/IFG组和NGT组血清内脂素水平低于NC组(P<0.05)。糖尿病组、IGT/IFG组和NGT组之间差异无统计学意义。血清内脂素水平与HOMA-IR及肥胖指标无相关性(P>0.05),但与空腹血糖、餐后2小时血糖及血压呈负相关(P<0.05)。
T2DM患者一级亲属在糖耐量受损发生前脂肪细胞因子谱已发生明显改变。内脂素血清水平对糖代谢有有益作用,在T2DM早期血清水平也显著降低。